Differential lipoprotein transport pathways of K-vitamins in healthy subjects

被引:168
作者
Schurgers, LJ
Vermeer, C
机构
[1] Maastricht Univ, Dept Biochem, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Inst Cardiovasc Res, NL-6200 MD Maastricht, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2002年 / 1570卷 / 01期
关键词
vitamin K; phylloquinone; menaquinone; absorption; lipoproteins; plasma transport;
D O I
10.1016/S0304-4165(02)00147-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin K is a group name for K, (phylloquinone) and K, (menaquinones). Both forms contribute to the tissue vitamin K status. Following intestinal absorption, the serum transport of these lipophilic compounds to their target tissues takes place via lipoproteins. In previous studies we have found that K, is preferentially accumulated in the liver. whereas menaquinones have a more widespread distribution pattern. Here we have tested whether these differences may be explained by the different liposolubility of the various K-vitamers, resulting in their association with different lipoprotein particles. Six healthy male volunteers received a mixture containing 2 mumol of each of three K vitamers (K-1, MK-4, and MK-9) dissolved in corn oil. Blood was obtained at baseline and at different time intervals after intake for the measurement of vitamin K in serum and in the lipoprotein fractions. During the first 4 h after intake all K-vitamins were found to be associated predominantly with the triacylglycerol-rich lipoprotein (TGRLP) fraction. Since the TGRLP fraction is mainly cleared by the liver, this suggests that initially most of the K-vitamins are transported to the liver. In contrast to K,, however, both menaquinones investigated were also found in TGRLP and low-density lipoprotein, whereas MK-4 was even present in high-density lipoprotein. This explains why menaquinones may have a different distribution profile and suggests a relatively large impact of menaquinones on extra-hepatic vitamin K status than generally assumed. Moreover, the very long half-life time of MK-9 in the circulation indicates that it may form a more constant source of vitamin K than are either K, or MK-4. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 30 条
[1]  
BJORNSON LK, 1975, J LIPID RES, V16, P39
[2]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[3]  
Brown MS, 1991, CURR OPIN LIPIDOL, V2, P65
[4]   Increased bone formation in osteocalcin-deficient mice [J].
Ducy, P ;
Desbois, C ;
Boyce, B ;
Pinero, G ;
Story, B ;
Dunstan, C ;
Smith, E ;
Bonadio, J ;
Goldstein, S ;
Gundberg, C ;
Bradley, A ;
Karsenty, G .
NATURE, 1996, 382 (6590) :448-452
[5]  
FURIE B, 1992, NEW ENGL J MED, V326, P800
[6]  
GELEIJNSE JM, 2001, THROMB HEAMOST S, V18, pP473
[7]   THE RELATIVE EFFECTS OF PHYLLOQUINONE AND MENAQUINONE-4 ON THE BLOOD-COAGULATION FACTOR SYNTHESIS IN VITAMIN K-DEFICIENT RATS [J].
GROENENVANDOOREN, MMCL ;
SOUTE, BAM ;
JIE, KSG ;
THIJSSEN, HHW ;
VERMEER, C .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (03) :433-437
[8]   CHYLOMICRON REMNANTS - HEPATIC RECEPTORS AND METABOLISM [J].
HAVEL, RJ .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (05) :312-316
[9]  
HAVEL RJ, 1995, METABOLIC MOL BASES, P1841
[10]   Nuclear vitamin K2 binding protein in human osteoblasts -: Homologue to glyceraldehyde-3-phosphate dehydrogenase [J].
Hoshi, K ;
Nomura, K ;
Sano, Y ;
Koshihara, Y .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (10) :1631-1638